Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jun 28, 2009; 15(24): 2995-3002
Published online Jun 28, 2009. doi: 10.3748/wjg.15.2995
Published online Jun 28, 2009. doi: 10.3748/wjg.15.2995
Table 1 Results of MTT test (mean ± SD)
| Group | Absorbance value | RGR (%) | Cytotoxicity gradations |
| Negative control | 0.4671 ± 0.0103 | 100.00 | 0 |
| 25% Fe2O3 | 0.4793 ± 0.0210 | 102.63 | 0 |
| 50% Fe2O3 | 0.4501 ± 0.0101 | 96.39 | 0 |
| 100% Fe2O3 | 0.4453 ± 0.0108 | 95.35 | 0 |
| 25% As2O3/Fe2O3 | 0.4373 ± 0.0210 | 93.64 | 0 |
| 50% As2O3/Fe2O3 | 0.1788 ± 0.0247 | 38.29 | 3 |
| 100% As2O3/Fe2O3 | 0.1273 ± 0.0073 | 27.26 | 3 |
| As2O3 (5 &mgr;mol/L) | 0.1322 ± 0.0090 | 30.12 | 3 |
| Positive control | 0.0733 ± 0.0050 | 15.70 | 4 |
- Citation: Wang ZY, Song J, Zhang DS. Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cells. World J Gastroenterol 2009; 15(24): 2995-3002
- URL: https://www.wjgnet.com/1007-9327/full/v15/i24/2995.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2995